SEDIVET DIN 02080001
Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: ROMIFIDINE HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | ROMIFIDINE HYDROCHLORIDE 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1994 |
| Current status date | 17-Sep-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24237 | 2020-09-17 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 6597 | 1999-12-09 | Supplement to a New Drug Submission (SNDS) | CHANGE IN MANUFACTURING OF ACTIVE INGREDIENT |
| 7506 | 1994-03-31 | New Drug Submission (NDS) |